Press Releases

Date	Title	Company
15-Dec-2021	OMass Founder, Professor Dame Carol Robinson, Honoured with the 2022 Louis-Jeantet Prize for Medicine and the 2022 Benjamin Franklin Medal in Chemistry	OMass Therapeutics
15-Dec-2021	Scientists reveal how the body controls allergy-causing immune cells	Francis Crick Institute
15-Dec-2021	Nanopharm Announces Expansion to Enable Full Services Solutions to Meet Increasing Customer Needs	Nanopharm
15-Dec-2021	Clasado steps up GPA engagement with executive board and committee appointments	Clasado
15-Dec-2021	UPS SURPASSES ONE BILLION COVID-19 VACCINE DELIVERY MILESTONE, CONTINUES TO DELIVER HOPE AROUND THE WORLD	UPS
15-Dec-2021	Oxford Spin-out Alethiomics launches to advance its multi-omics target discovery pipeline in blood cancer, as highlighted in ASH plenary	Alethiomics
15-Dec-2021	SciRhom Establishes a World-Class Clinical Advisory Board	SciRhom GmbH
15-Dec-2021	A year of international growth and product advancement	Biocomposites
15-Dec-2021	Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing	Depixus
15-Dec-2021	Abzena Promotes Troy Wright to Senior Vice President and Global Head of Quality	Abzena
15-Dec-2021	GW Pharmaceuticals receives approval for the reimbursement of Epidyolex® (cannabidiol) for the treatment of seizures associated with Tuberous sclerosis complex in Wales	GW Pharmaceuticals
15-Dec-2021	Sareum receives ‘Intention to Grant’ Notification from the European Patent Office for its TYK2/JAK1 inhibitor SDC-1802	Sareum
15-Dec-2021	Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene’s Invir.IO™ Platform	Transgene
15-Dec-2021	Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation	Sanofi and GSK
15-Dec-2021	Bionaut Labs and Candel Therapeutics Announce Strategic Collaboration in Precision-Targeted Delivery of Oncolytic Viral Immunotherapies	Bionaut Labs
15-Dec-2021	Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions	Carterra
15-Dec-2021	Freeline Announces 2022 Corporate Priorities and Guidance	Freeline
15-Dec-2021	OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 covering OKYO Pharma’s drug candidate OK-101 for use to treat dry eye disease	OKYO Pharma
15-Dec-2021	HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting	HUTCHMED
15-Dec-2021	CSL Limited announces tender offer to acquire Vifor Pharma Ltd	CSL Limited